Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
editorial
. 1984 May;59(5):397–400. doi: 10.1136/adc.59.5.397

Haemolytic uraemic syndrome.

M Levin, J M Barratt
PMCID: PMC1628493  PMID: 6375582

Full text

PDF
399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brain M. C. The haemolytic-uraemic syndrome. Semin Hematol. 1969 Apr;6(2):162–180. [PubMed] [Google Scholar]
  2. Bukowski R. M., King J. W., Hewlett J. S. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood. 1977 Sep;50(3):413–417. [PubMed] [Google Scholar]
  3. Burns E. R., Zucker-Franklin D. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood. 1982 Oct;60(4):1030–1037. [PubMed] [Google Scholar]
  4. Chen Y. C., McLeod B., Hall E. R., Wu K. K. Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura. Lancet. 1981 Aug 8;2(8241):267–269. doi: 10.1016/s0140-6736(81)90522-5. [DOI] [PubMed] [Google Scholar]
  5. Fong J. S., Kaplan B. S. Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion". Blood. 1982 Sep;60(3):564–570. [PubMed] [Google Scholar]
  6. George C. R., Slichter S. J., Quadracci L. J., Striker G. E., Harker L. A. A kinetic evaluation of hemostasis in renal disease. N Engl J Med. 1974 Nov 21;291(21):1111–1115. doi: 10.1056/NEJM197411212912105. [DOI] [PubMed] [Google Scholar]
  7. Kaplan B. S., Chesney R. W., Drummond K. N. Hemolytic uremic syndrome in families. N Engl J Med. 1975 May 22;292(21):1090–1093. doi: 10.1056/NEJM197505222922102. [DOI] [PubMed] [Google Scholar]
  8. Karmali M. A., Steele B. T., Petric M., Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983 Mar 19;1(8325):619–620. doi: 10.1016/s0140-6736(83)91795-6. [DOI] [PubMed] [Google Scholar]
  9. Katz J., Krawitz S., Sacks P. V., Levin S. E., Thomson P., Levin J., Metz J. Platelet, erythrocyte, and fibrinogen kinetics in the hemolytic-uremic syndrome of infancy. J Pediatr. 1973 Nov;83(5):739–748. doi: 10.1016/s0022-3476(73)80364-6. [DOI] [PubMed] [Google Scholar]
  10. Klein P. J., Bulla M., Newman R. A., Müller P., Uhlenbruck G., Schaefer H. E., Krüger G., Fisher R. Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome. Lancet. 1977 Nov 12;2(8046):1024–1025. doi: 10.1016/s0140-6736(77)92915-4. [DOI] [PubMed] [Google Scholar]
  11. Koster F., Levin J., Walker L., Tung K. S., Gilman R. H., Rahaman M. M., Majid M. A., Islam S., Williams R. C., Jr Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med. 1978 Apr 27;298(17):927–933. doi: 10.1056/NEJM197804272981702. [DOI] [PubMed] [Google Scholar]
  12. Levin M., Elkon K. B., Nokes T. J., Buckle A. M., Dillon M. J., Hardisty R. M., Barratt T. M. Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome. Arch Dis Child. 1983 Sep;58(9):703–708. doi: 10.1136/adc.58.9.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lian E. C., Harkness D. R., Byrnes J. J., Wallach H., Nunez R. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma. Blood. 1979 Feb;53(2):333–338. [PubMed] [Google Scholar]
  14. Misiani R., Appiani A. C., Edefonti A., Gotti E., Bettinelli A., Giani M., Rossi E., Remuzzi G., Mecca G. Haemolytic uraemic syndrome: therapeutic effect of plasma infusion. Br Med J (Clin Res Ed) 1982 Nov 6;285(6351):1304–1306. doi: 10.1136/bmj.285.6351.1304. [DOI] [PubMed] [Google Scholar]
  15. Moake J. L., Rudy C. K., Troll J. H., Weinstein M. J., Colannino N. M., Azocar J., Seder R. H., Hong S. L., Deykin D. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982 Dec 2;307(23):1432–1435. doi: 10.1056/NEJM198212023072306. [DOI] [PubMed] [Google Scholar]
  16. Moncada S., Vane J. R. Prostacyclin: its biosynthesis, actions and clinical potential. Philos Trans R Soc Lond B Biol Sci. 1981 Aug 18;294(1072):305–329. doi: 10.1098/rstb.1981.0108. [DOI] [PubMed] [Google Scholar]
  17. Remuzzi G., Mecca G., Livio M., de Gaetano G., Donati M. B., Pearson J. D., Gordon J. L. Prostacyclin generation by cultured endothelial cells in haemolytic uraemic syndrome. Lancet. 1980 Mar 22;1(8169):656–657. doi: 10.1016/s0140-6736(80)91153-8. [DOI] [PubMed] [Google Scholar]
  18. Remuzzi G., Misiani R., Marchesi D., Livio M., Mecca G., de Gaetano G., Donati M. B. Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet. 1978 Oct 21;2(8095):871–872. doi: 10.1016/s0140-6736(78)91573-8. [DOI] [PubMed] [Google Scholar]
  19. Seger R., Joller P., Baerlocher K., Kenny A., Dulake C., Leumann E., Spierig M., Hitzig W. H. Hemolytic-uremic syndrome associated with neuraminidase-producing microorganisms: treatment by exchange transfusion. Helv Paediatr Acta. 1980 Sep;35(4):359–367. [PubMed] [Google Scholar]
  20. Stuart M. J., Spitzer R. E., Coppe D. Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome. Pediatrics. 1983 Jan;71(1):120–124. [PubMed] [Google Scholar]
  21. Trompeter R. S., Schwartz R., Chantler C., Dillon M. J., Haycock G. B., Kay R., Barratt T. M. Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch Dis Child. 1983 Feb;58(2):101–105. doi: 10.1136/adc.58.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES